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Beclin 1, a subunit of the class III phosphatidylinositol 3-
kinase complex, is a tumour suppressor with a central role
in endocytic trafﬁcking, cytokinesis and the cross-regulation
between autophagy and apoptosis. Interestingly, not only reduced
expression but also overexpression of Beclin 1 is correlated with
cancer development and metastasis. Thus it seems necessary
for the cell to balance the protein levels of Beclin 1. In the
present study we describe a regulatory link between Beclin 1
and the ubiquitin ligase Nedd4 (neural-precursor-cell-expressed
developmentally down-regulated 4). We establish Nedd4 as a
novel binding partner of Beclin 1 and demonstrate that Nedd4
polyubiquitinates Beclin 1 with Lys
11-a n dL y s
63-linked chains.
Importantly, Nedd4 expression controls the stability of Beclin
1, and depletion of the Beclin 1-interacting protein VPS34
causes Nedd4-mediated proteasomal degradation of Beclin 1
via Lys
11-linked polyubiquitin chains. Beclin 1 is thus the ﬁrst
tumour suppressor reported to be controlled by Lys
11-linked
polyubiquitination.
Keywords:cancer,homologouswithE6-associatedproteinC-ter-
minus (HECT), neural-precursor-cell-expressed developmentally
down-regulated 4 (Nedd4), phosphoinositide, ubiquitination,
VPS34.
INTRODUCTION
Phosphoinositides, phosphorylated derivatives of PtdIns, control
cellular functions through recruitment of cytosolic proteins
to speciﬁc membranes. The PI3K-III (class III PI 3-kinase)
complex, which catalyses the conversion of PtdIns into PtdIns3P,
is involved in at least three topologically related membrane
involution processes: autophagy [1] and cytokinesis [2], as well
as endocytic trafﬁcking and signalling [3]. The dysfunction of
PtdIns3Pgenerationisdirectlylinkedtotheoccurrenceofseveral
diseases, including different types of cancer [4]. The assembly
of the PI3K-III complex is suggested to occur in a sequential
manner. Initially, the regulatory subunit VPS15/PIK3R4/p150
associates with speciﬁc membranes and recruits the catalytic
subunit VPS34/PIK3C3. Together with VPS15 and VPS34, the
coiled-coil protein Beclin 1 is thought to form the core of
the PI3K-III complex, and accumulating evidence suggests that
Beclin 1 serves as a platform for the recruitment of transiently
associated regulatory proteins [5,6]. The importance of Beclin
1 is underscored by the ﬁnding that low cellular concentrations
of Beclin 1 are often associated with the occurrence of cancer
[7,8]. However, it is important to also note that overexpression
of Beclin 1 is correlated with prolonged survival of a subset of
tumour cells, most likely by promoting autophagy and thereby
preventing apoptosis [9,10]. In general, the question of how and
when Beclin 1-mediated autophagy has a positive or negative
effect on tumorigenesis is not fully resolved [11].
Beclin1hasamodulararchitecturewhichfacilitatesdifferential
interactionwithvariousbindingpartners.Theinteractionwiththe
PI3K-III catalytic subunit VPS34 is mediated both by the ECD
(evolutionarily conserved domain) [12] and by regions of the
CCD (coiled-coil domain). The latter also serves as a binding
site for UVRAG (UV radiation resistance-associated gene), a
positive regulator of PI3K-III complex activity [13]. The BH3
(Bcl-2 homology 3) domain is required for the association with
Bcl-2 family members [14], which act as inhibitors of Beclin
1’s function in autophagy. The list of Beclin 1 effectors is still
growing [6] and gives rise to the notion that the stoichiometry
of the Beclin 1-associated proteins targets the VPS34 complex
to its different functions in autophagy, endocytic trafﬁcking and
cytokinesis [5]. Thus the availability of the active pool of Beclin
1 to associate with VPS34 and in turn to promote PtdIns3P
signalling is tightly governed by a subset of regulatory factors.
First, Beclin 1 can be regulated at the level of protein expression,
which is usually increased during autophagy [15]. In this context,
it has been described that the expression of the BCN1 gene is
induced via 14-3-3τ and E2F1 [16]. Furthermore, the activity of
the Beclin 1 protein is titrated by its interaction with Bcl-2 family
members [14]. At the post-translational modiﬁcation level Beclin
1canbephosphorylatedbyDAP(death-associatedprotein)kinase
within its BH3 domain in order to reduce its interaction with
Bcl-2 [17]. Recently, it has also been demonstrated that TRAF6
(tumour-necrosis-factor-receptor-associated factor 6)-dependent
ubiquitination, which is supposed to function non-proteolytically,
activates Beclin 1 during early autophagy, as this modiﬁcation
occurs within the BH3 domain and inhibits the interaction with
Bcl-2 [18].
EventhoughseveralregulatorsofBeclin1havebeenidentiﬁed,
it is not known how the stability of this tumour suppressor is
controlled. In the present study we provide evidence for a novel
typeofregulatorymechanismofhumanBeclin1.Wedemonstrate
that Beclin 1 is polyubiquitinated by the HECT (homologous
with E6-associated protein C-terminus) ligase Nedd4 (neural-
precursor-cell-expresseddevelopmentallydown-regulated4)with
Lys
11-a n dL y s
63-linked Ub (ubiquitin) chains and that the former
post-translational modiﬁcation regulates the stability of Beclin 1.
Abbreviations used: AIP4, atrophin-interacting protein 4; BH3, Bcl-2 homology 3; CCD, coiled-coil domain; CHX, cycloheximide; DMEM, Dulbecco’s
modiﬁed Eagle’s medium; DTT, dithiothreitol; ECD, evolutionarily conserved domain; GST, glutathione transferase; HA, haemagglutinin; HECT, homologous
with E6-associated protein C-terminus; HRP, horseradish peroxidase; Nedd4, neural-precursor-cell-expressed developmentally down-regulated 4; PI3K-III,
class III PI 3-kinase; siRNA, small interfering RNA; TRAF6, tumour-necrosis-factor-receptor-associated factor 6; Ub, ubiquitin.
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EXPERIMENTAL
Plasmids
The pCXN2-Nedd4 construct (from Professor Sharad Kumar,
CentreforCancerBiology,SAPathology,FromeRoad,Adelaide,
SA, Australia) was cut with EcoRI and Nedd4 was ligated into
pET21d, resulting in pET21d-His-Nedd4. The WW-fragment,
containing the WW-motifs 1–3, was generated by using Nedd4
as a PCR template. The PCR fragment was restricted with
BamHI/XhoI and cloned into the BamHI/XhoI sites of pGAD-
GH2 or pcDNA3, from where it was cut with EcoRI/XbaI in
order to be ligated into pET21d to generate His–Nedd4–(WW).
The Myc–Nedd4 fusion and the Myc–Nedd4-2 construct (from
ProfessorJonHuibregtse,CellandMolecularBiology,University
of Texas at Austin, TX, U.S.A.) as well as the Myc–AIP4
(atrophin-interacting protein 4) (from Dr Tony Pawson, Samuel
Lunenfeld Research Institute, Mount Sinai Hospital, Toronto,
Ontario, Canada) construct were expressed from pcDNA3. The
fusion proteins Myc–Beclin 1, GST (glutathione transferase)–
Beclin 1 and pGAD-Beclin 1 as well as pLexA-VPS34 were
from Dr Anne Simonsen (Institute of Basic Medical Sciences,
Faculty of Medicine, University of Oslo, Oslo, Norway). The
Y352A point mutation was introduced in Beclin 1 using overlap
extension PCR. The different HA (haemagglutinin)-tagged Ub
species were expressed from pcDNA3 and comprised HA–Ub,
HA–Ub-K0, HA–Ub-Lys
6, HA–Ub-Lys
11, HA–Ub-Lys
29, HA–
Ub-Lys
48 andHA–Ub-Lys
63 (fromDrVishvaDixit,Departmentof
Physiological Chemistry, Genentech, South San Francisco, CA,
U.S.A.). The sequences of the PCR oligonucleotides used are
available upon request.
Cell culture and transfections
Media and reagents for cell culture were purchased from Gibco.
HeLa cells were grown in DMEM (Dulbecco’s modiﬁed Eagle’s
medium) containing 10% FBS (fetal bovine serum), 5 units/ml
penicillinand50 μg/mlstreptomycin.Cellsweretransfectedwith
the above expression plasmids using the FuGENE
TM 6 reagent
(RocheMolecularBiochemicals)accordingtothemanufacturer’s
instructions.
siRNA (small interfering RNA) treatment
ON-Target Plus siRNAs were from Dharmacon. Pre-designed
oligonucleotides included scrambled siRNA (D-001810-01),
siRNAs speciﬁc for VPS34 (D-005250-04) and Nedd4 (from
Dr Edward Leithe, Department of Cancer Prevention, Institute
for Cancer Research, Oslo University Hospital, Oslo, Norway).
siRNA oligonucleotides were complexed with Lipofectamine
TM
RNAiMax transfection reagent (Invitrogen) in DMEM without
serum, penicillin or streptomycin, and added to cells at 50%
conﬂuency in penicillin- and streptomycin-free DMEM, at a ﬁnal
siRNA concentration of 70 nM. After 16 h, cells were washed
twice in DMEM and maintained in DMEM for a total of 96 h
post-transfection [19].
CHX (cycloheximide) chase
HeLa cells were transfected where indicated and cultured for
20 h. After a 10 h incubation with 25 μg/ml CHX, in the presence
or absence of 10 μM lactacystine or 20 μM MG132, the cells
were lysed and analysed by SDS/PAGE (4–20% gels) and
immunoblottingtoassesstheamountofundegradedprotein.Actin
or tubulin were used as the loading controls.
Immunoblotting and antibodies
HeLa cells were lysed in buffer [25 mM Hepes, pH 7.2, 125 mM
potassium acetate, 2.5 mM magnesium acetate, 5 mM EGTA,
1 mMDTT(dithiothreitol),0.5%NonidetP40and1:100protease
inhibitor mix (Roche Applied Science)]. After centrifugation
for 5 min at 20000 g, the whole cell lysate was collected
and subjected to SDS/PAGE. The proteins were transferred on
to Immobilon-P membranes (Millipore) and visualized after
immunoblotting using the Supersignal West Pico Substrate kit
(Pierce). Rabbit polyclonal antibodies against VPS34 and Beclin
1 were purchased from Cell Signaling Technology. Rabbit anti-
Nedd4 antibody was a gift from Dr Edward Leithe. Mouse anti-
β-actin and mouse anti-α-tubulin antibodies were from Sigma–
Aldrich, whereas mouse anti-HA antibody was from Roche. The
mouse monoclonal antibody against the c-Myc epitope was from
the 9E10 hybridoma [19a]. Secondary antibodies were all from
Jackson Immunoresearch Laboratories, and included anti-mouse
HRP (horseradish peroxidase) and anti-rabbit HRP.
Immunoprecipitation
HeLa cells in 10-cm-diameter culture dishes were lysed in
ice-cold lysis buffer (20 mM Hepes, pH 7.2, 2 mM MgCl2,
100 mM NaCl, 0.1 mM EDTA and 0.1% Triton X-100)
containing inhibitors [10 mM N-ethylmaleimide, mammalian
protease inhibitor mixture, phosphatase inhibitor cocktail I and
II (Sigma–Aldrich)]. The lysates were cleared by centrifugation
at4◦Cfor15 minat10000 g.Thepre-clearedlysate(1 mgoftotal
cellextract)wastransferredtoanewtubeandincubatedwith1 μg
ofantibodyfor90 minend-over-endat4◦C(totalvolume500 μl).
Protein A–Sepharose (30 μl; GE Healthcare Bio-Sciences AB)
was added, followed by an incubation for 60 min at 4◦C. The
Protein A slurry bound to the antibody and associated protein
complexes was pelleted by centrifuging for 30 s at 25000 g.T h e
pellet was washed three times with 1 ml of lysis buffer. After the
ﬁnal wash, 30 μlo f2 × Laemmli sample buffer supplemented
with 50 mM DTT was added and the samples were boiled for
5m i na t9 5◦C.
In vivo ubiquitination
HeLa cells were grown on 10-cm-diameter dishes in the
presence of 20 μM MG132 and were transiently transfected with
HA–Ub (3 μg) and 1 μg Myc–Beclin 1 as well as 1 μg of Nedd4,
Myc–Nedd4,Myc–Nedd4-2orMyc–AIP4asindicated.Todetect
ubiquitinated Beclin 1, cells were scraped in 1 ml Triton X
buffer (150 mM NaCl, 20 mM Tris/HCl, pH 7.4, 5 mM EDTA,
1m MC a C l 2,1% Triton X-100, 5% glycerol, 10 mM NaF and
10 mMsodiumorthovanadatewithproteaseinhibitorsand10 mM
N-ethylmaleimide). Lysates were subjected to immunoprecipita-
tion.
Expression and puriﬁcation of recombinant proteins
His-tagged fusion proteins were expressed in Escherichia
coli BL21 cells after induction with IPTG (isopropyl β-D-
thiogalactopyranoside). The cells were lysed in lysis buffer
(25 mM Tris/HCl, pH 8.0, 50 mM NaCl, 0.5% Triton X-100,
10% glycerol and 10 mM imidazole). The cell lysates were
cleared by 14000 rev./min centrifugation at 4◦C for 20 min,
and the cleared lysates was incubated with Ni-NTA (Ni
2+-
nitrilotriacetate) agarose beads at 4◦C with rotation for 2 h.
The Ni
2+-beads were washed three times with lysis buffer
containing 20 mM imidazole. The bead-bound Nedd4 was eluted
by incubation of the beads with elution buffer (25 mM Tris/HCl,
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pH 8.0, 50 mM NaCl, 10% glycerol and 250 mM imidazole) at
4◦C with rotation for 15 min. The eluted Nedd4 was dialysed
overnight in dialysis buffer (25 mM Tris/HCl, pH 8.0, 100 mM
NaCland2 mMMgCl2)[20].GST-fusionproteinswereexpressed
in E. coli BL21 cells and puriﬁed by afﬁnity puriﬁcation with
glutathione–agarose beads as described previously [17].
In vitro ubiquitination
The in vitro ubiquitination experiments were based on methods
describedpreviously[20,21]withminormodiﬁcations.Theassay
is based on a reaction mixture (15 μl) containing 0.1 μgo f
GST–Beclin 1, 0.1 μg of E1, 0.5 μgo fU b c H 5 a ,5 μgo fU b
and buffer (2 mM ATP, 25 mM Tris/HCl, pH 8.0, 100 mM NaCl,
2.0 mM MgCl2 and 1 mM DTT) For an activation of Nedd4,
a1 . 2 5m MC a C l 2 solution (5 μl) was added to the His–Nedd4
(0.1 μgi n1 0μl) before subjecting both to the assay reaction
mixture. The reaction was initiated by addition of Nedd4 to the
reaction mixture, carried out at 22◦C for 20 min and stopped by
adding 25 μlo f2 × SDS/PAGE sample buffer.
Yeast two-hybrid assay
The yeast reporter strain L40 was transformed as described
previously [22] with the yeast two-hybrid plasmids pLexA and
pGAD, and grown on synthetic medium lacking tryptophan
and leucine at 30◦C. The double transformants obtained were
grown at 30◦C for 16 h in liquid synthetic medium. Lysates
from these cells were prepared and subsequently subjected to
β-galactosidase assays as described previously [23].
RESULTS
Nedd4 interacts with Beclin 1
ToobtainpotentialcluesfortheregulationofBeclin1stability,we
utilized various bioinformatic algorithms to analyse the protein
sequence. Using tools for multiple sequence alignments, we
identiﬁed a sequence resembling a PY motif (LPxY), a potential
target for WW domains, in Beclin 1 (Figure 1A). The motif is
well conserved from yeast to humans and, in humans, Beclin
1 is located downstream of the ECD at amino acid positions
349–352. Interestingly, the PY motif is also conserved in a plant
homologue of Beclin 1, but is located in the N-terminal portion
of the protein (results not shown). Both the canonical LPxY as
well as the LPxF variant found in Beclin 1 of Brugia malayi
represent sequence motifs that have been described to function as
bindingsitesforNedd4/Rsp5-likeUb-isopeptideligasesinseveral
proteins [24,25]. The general concept is that the PY motif of the
target protein has to interact speciﬁcally with the WW domains
found in the Nedd4-like ligase in order to become ubiquitiated
[26]. We adressed the question of whether human Beclin 1 is
capable of interacting with Nedd4-like ligases by testing its
interaction with the WW domains of Nedd4, Nedd4-2 and AIP4
in a yeast two-hybrid assay (Figure 1B). Beclin 1 was found
to interact with all three variants of this conserved interaction
module, with Nedd4(WW) displaying the strongest afﬁnity in
this assay. In contrast, none of the three WW-motifs were able
to interact with VPS34, the major binding partner of Beclin 1,
indicatingthattheobservedinteractionbetweenWWdomainsand
Beclin 1 is speciﬁc. These results provide evidence that Beclin
1 is a ligand for WW motifs. On the basis of the observation
that Nedd4(WW) gave the strongest interaction in the yeast two-
hybridassay,wetestedifthefull-lengthproteinsinteractinhuman
cells (Figure 1C). For this purpose, we transiently transfected
Figure 1 Beclin 1 interacts with Nedd4
(A) Human Beclin 1 has been described as containing a BH3 domain, a CCD and an ECD.
Amino acid sequence alignments suggest that Beclin 1 contains a PY motif in addition. (B) The
interactionoftheWWfragmentsofNedd4,Nedd4-2andAIP4weretestedagainstBeclin1(upper
panel)aswellasVPS34(lowerpanel)inyeasttwo-hybridassaysbymeasuringβ-galactosidase
activity.(C)Myc–Beclin1wastransfectedintoHeLacellsandimmunopreciptated(IP)viatheMyc
tag.VPS34aswellasNedd4,butnottubulin,couldbeco-isolatedwithBeclin1.(D)Recombinant
GST-Beclin 1 and His-Nedd4 as well as His-Nedd4(WW) were expressed heterologously in E.
coli cells.Thefull-lengthaswellastheWWfragmentofNedd4wereco-elutedwithGST–Beclin
1, but not with GST alone from GSH columns. IB, immunoblot; TCL, total cell lysate.
HeLa cells with Myc-tagged Beclin 1 and untagged Nedd4 and
performed co-immunoprecipitation experiments via the Myc tag.
As a result, a fraction of Nedd4 was co-isolated along with the
knownbindingpartnerVPS34,indicatingthatBeclin1andNedd4
can associate in vivo. In order to elucidate whether the observed
association indeed represents a direct interaction, we puriﬁed
GST–Beclin 1 and His-tagged Nedd4 as well as the WW-domain
fragment from E. coli (Figure 1D). Using a glutathione column,
we were able to co-elute GST–Beclin 1 with His–Nedd4 or His–
Nedd4(WW). In contrast, none of the Nedd4 proteins could be
co-elutedwithGSTalone,stronglysuggestingadirectassociation
of Beclin 1 with the WW fragment of Nedd4. In summary, these
results establish Nedd4 as a novel Beclin 1-interacting protein.
The stability of Beclin 1 is reciprocally regulated by Nedd4 and
VPS34
The association of Beclin 1 with the ligase Nedd4 suggested
that the regulation of the protein concentration of Beclin 1
might be linked to ubiquitination events. To investigate this,
we blocked protein synthesis by the addition of CHX to the
cells and monitored the protein level of Beclin 1 depending on
time and different inhibitors of proteasomal protein degradation
(Figure 2A). The results show that the level of Beclin 1, in
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Figure 2 VPS34 and Nedd4 regulate the stability of Beclin 1
(A) CHX was added to the indicated samples in order to block protein synthesis. The observed
partial turnover of Beclin 1 could be stopped in part by the proteasomal inhibitors MG132 and
lactacystin.(B)QuantiﬁcationofBeclin1proteinlevelsforeachexperimentalcondition.Numbers
representproteinlevelsexpressedasthepercentageofthosefromuntreatedcellsandnormalized
to actin. Error bars represent means+ −S.E.M. on the basis of results from three independent
experiments. (C) HeLa cells overexpressing transiently transfected Myc–Nedd4, Myc–Nedd4-2
or Myc–AIP4 were lysed and analysed for the stability of Beclin 1. (D) Quantiﬁcation of Beclin
1 and VPS34 protein levels for each experimental condition. Numbers represent protein levels
expressedasthepercentageofthosefromcellswithemptyvectorandnormalizedtotubulin.Error
bars represent means+ −S.E.M. on the basis of results from three independent experiments.
(E) HeLa cells treated with the indicated siRNA were lysed and proteins were detected by
immunoblotting.siRNAdirectedagainstVPS34inducedthedestabilizationofBeclin1,whereas
the siRNA against Nedd4 stabilized Beclin 1.
contrast with the control protein actin, was decreased 10 h after
theadditionofCHXandthatthisbasalturn-overcouldbeblocked
toacertainextentbysupplementingthecellswiththeproteasomal
inhibitors MG132 or lactacystin (Figures 2A and 2B). Since
Beclin 1 could interact with the WW domains of Nedd4, Nedd4-2
and AIP4 (Figure 1B), we tested if the steady-state concentration
of Beclin 1 could be affected by overexpression of the full-length
versions of these three HECT ligases (Figure 2C). Although
overexpressionofNedd4-2andAIP4hadonlyamarginaleffecton
the Beclin 1 level, overexpression of Nedd4 signiﬁcantly reduced
the Beclin 1 concentration. In contrast, the steady-state level
of VPS34 remained unchanged in all experiments (Figures 2C
and 2D). Similar results were obtained in CHX assays, where
overexpression of Nedd4 reduced the half-life of Beclin 1 but not
VPS34 compared with the cells expressing empty vector (results
not shown).
Since Beclin 1 binds both VPS34 and Nedd4, we investigated
the functional relationship of endogenous VPS34 and Nedd4
by siRNA treatment (Figure 2E). siRNA-mediated depletion of
VPS34 reduced the level of Beclin 1, as previously reported
[19], whereas Nedd4 levels remained unaffected. The depletion
of Nedd4 resulted in a moderate increase in the level of Beclin 1,
but had no effect on VPS34. Taken together, the data suggest
that the steady-state concentration of Beclin 1 is controlled
by antagonizing factors. Although the major binding partner
VPS34 stabilizes Beclin 1, the HECT ligase Nedd4 promotes
its degradation by the proteasome.
Figure 3 Beclin 1 is ubiquitinated by Nedd4
(A) HeLa cells were transfected with HA–Ub, Myc–Beclin 1 or empty pcDNA3 plasmid. The
proteasomal inhibitor MG132 was added to the cells where indicated. Myc–Beclin 1 was
immunoprecipitated (IP) using the anti-Myc antibody. The samples of the IP eluate as well as of
thetotalcelllysate(TCL)wereanalysedbySDS/PAGEandimmunoblotting(IB)withanti-HAand
anti-Beclin1antibodies.(B)Beclin1wasimmunoprecipitatedfromcellsexpressingtheligases
Myc–Nedd4, Myc–Nedd4-2 and Myc–AIP4 as well as empty vector. Samples were subjected
to SDS/PAGE and analysed by anti-HA and anti-Myc antibodies. (C) Heterologously expressed
and puriﬁed GST–Beclin 1 was subjected to in vitro ubiquitination assays. UbcH5a served as
the Ub-conjugating enzyme, whereas His–Nedd4 served as the Ub ligase. The dependency of
Beclin 1 ubiquitination on the activity of Nedd4 was tested by using the Nedd4 WW-domain
fragment, which lacks the catalytic HECT domain, or by omitting the Ca2+ ions, which are
required for releasing Nedd4 from its autoinhibition. Modiﬁed and unmodiﬁed GST–Beclin 1
species were visualized by the anti-GST antibody.
Beclin 1 is ubiquitinated by Nedd4
The ﬁnding that the concentration of Beclin 1 is inﬂuenced by
the HECT ligase Nedd4 strongly suggested that Beclin 1 is
post-translationally modiﬁed with Ub. To test this hypothesis
we transiently transfected cells with HA–Ub and isolated Myc–
Beclin 1. Analysis of the precipitates revealed that several
slower migrating Beclin 1 species could be detected with the
Beclin 1 antibody (Figure 3A). These signals were signiﬁcantly
enhanced when proteasomal activity was inhibited with MG132.
The immunoblot stained with the anti-HA antibody to detect
ubiquitinated species displayed signals that correspond to the
Beclin 1-positive high-molecular mass species. Additionally,
these signals become more intense in samples derived from
MG132-treated cells. Taken together, these data indicate that
Beclin 1 is ubiquitinated in vivo.
In order to identify the E3 Ub ligase responsible for the
ubiquitinationofBeclin1,weoverexpressedNedd4,Nedd4-2and
AIP4inhumancells,addedMG132andanalysedtheeffectonthe
ubiquitination of Beclin 1 (Figure 3B). The enhanced expression
of Nedd4 resulted in an increase of the ubiquitinated Beclin 1
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species, whereas Nedd4-2 and AIP4 had no signiﬁcant effect
under the chosen conditions.
In order to exclude the possibility that Nedd4 might act
indirectlyonBeclin1,weinvestigatedwhetherNedd4candirectly
ubiquitinate Beclin 1 in vitro (Figure 3C). For this purpose
we used heterologously expressed GST–Beclin 1, His6-tagged
Nedd4, puriﬁed E1 Ub-activating enzyme and Ub. UbcH5a was
used as an E2 Ub-conjugating enzyme, because it is known to
co-operate with Nedd4 [27]. The in vitro Ub assay revealed a
direct ubiquitination of Beclin 1 by Nedd4 (Figure 3C). Beclin 1
was not modiﬁed when Nedd4 was auto-inhibited by the absence
of Ca
2+ or when a truncated version of Nedd4 consisting of the
WW fragment only was included in the assay, indicating that
the enzymatically active HECT domain of Nedd4 is required
for the ubiquitination of Beclin 1. In conclusion, these results
identify Nedd4 as an E3 Ub ligase for Beclin 1.
Mutation of the PY motif affects ubiquitination and stability of
Beclin 1
In order to verify that the putative PY-motif in Beclin 1 indeed
serves as the binding site with Nedd4, we mutated Tyr
352 to
an alanine residue. The Beclin 1(Y352A) mutant displayed a
signiﬁcantly reduced interaction with the WW domain of Nedd4
in yeast two-hybrid assays (Figure 4A). As the binding to VPS34
was unaffected, we conclude that the PY motif functions as a
speciﬁc Nedd4-binding site. In line with this, Beclin 1(Y352A)
proved to be more stable than the wild-type protein in CHX chase
assays (Figure 4B). Furthermore, the Y352A mutation reduced
the ubiquitination of Beclin 1 signiﬁcantly (Figure 4C). The fact
that the modiﬁcation of mutated Beclin 1 was not completely
blocked indicates that the point mutation does not completely
inhibit the interaction to Nedd4, which would be in agreement
with Figure 4(A). However, the presented data suggest that the
PY motif in Beclin 1 is a functional link to Nedd4-mediated
ubiquitination.
Nedd4 modiﬁes Beclin 1 with Lys11- and Lys63-linked polyUb chains
TheUbmoietieswithinapolyUbchaincanbelinkedviadifferent
lysine residues of Ub. Different Ub linkages are believed to result
in various conformations of Ub chains and are thought to create
a range of molecular signals [28]. In order to deﬁne the Ub chain
linkage of Beclin 1, we expressed HA-tagged versions of single
lysine mutants of Ub that allow the formation of Ub chains via
one lysine residue only. After co-transfecting Nedd4 with HA-
tagged fusions of Ub, Ub-K0, -Lys
6-, -Lys
11-, -Lys
29-, -Lys
48-
and -Lys
63-only constructs in MG132-treated cells, we performed
immunoprecipitationofMyc–Beclin1(Figure5A).Weexpected,
as described previously [29], to ﬁnd Ub-positive signals even in
the samples of the UbK0-expressing cells. As the endogenous Ub
is still present, HA–Ub is only statistically added to chains of
different length. However, the incorporation of Ub forms that are
incompatible with the investigated E3/substrate combination will
stop chain elongation and thus result in a lower abundance of Ub
chains. In the case of Ub–Beclin 1, only the Ub-Lys
11 and Ub-
Lys
63 samples displayed Ub-positive signals similar to the wild-
type Ub sample, whereas all other Ub mutants mainly suppressed
the formation of Ub chains. These data suggest that Beclin 1
can be modiﬁed by Lys
11-a n dL y s
63-linked polyubiquitin chains.
This enhanced generation of both chain types was not visible
when Nedd4-2 or AIP4 instead of Nedd4 were overexpressed
(results not shown), indicating that the modiﬁcations of Beclin 1
are catalysed by Nedd4.
Figure 4 The mutation of the PY motif interferes with Nedd4-mediated
ubiquitination
(A) The Y352A mutantion of Beclin 1 reduces the interaction with Nedd4, but not with VPS34,
in yeast two-hybrid assays. (B) The Y352A mutant is more stable in CHX chase assays than
wild-type Beclin 1. (C) HeLa cells transfected with Nedd4, Myc-tagged versions of Beclin 1 as
well as HA–Ub were subjected to immunoprecipitation with anti-Myc antibodies. Analysis of
the samples revealed that the Y352A mutant was less modiﬁed than the Beclin 1 with an intact
PY motif. IB, immunoblot; IP, immunoprecipitation.
Degradation of Beclin 1 is mediated by Lys11-linked polyUb chains
To further understand the relationship between Beclin 1, VPS34
and Nedd4-mediated ubiquitination, we analysed the VPS34-
depletion-induced instability of Beclin 1 in further detail
(Figure 5B). As described previously (Figure 2E), the
siRNA-mediated reduction of VPS34 protein levels results in
destabilization of endogenous Beclin 1. This effect was still
observed when Myc–Beclin 1 was co-expressed with Nedd4 and
HA–Ub fusions. Interestingly, although the level of Myc–Beclin
1 was signiﬁcantly reduced, the ubiquitination of Myc–Beclin 1
wasenhancedwhentheproteasomewasinhibitedsimultaneously.
This indicates that the decrease of Beclin 1 is accomplished by its
polyubiquitination and proteasomal degradation.
In order to determine if this proteasomal turnover of Beclin 1
ismediatedbyLys
11-orL ys
63-linkedUb-chains,Ub–Beclin1was
isolatedfromcellsexpressingtheindicatedUbmutants.Although
Lys
63-linked Ub-chains could be found on Beclin 1 in the
presence of VPS34 (Figure 5B), they did not mediate the
enhanced ubiquitination of Beclin 1 when VPS34 was depleted
and Beclin 1 was destabilized. The expression of Ub-Lys
63
in VPS34 siRNA-treated cells reduced the formation of the
ubiquitinated Beclin 1 species compared with expression of wild-
type Ub. However, Ub-Lys
63 did not rescue the breakdown of
Beclin 1, as there was still enough endogenous Ub to promote
degradation. In contrast, as only samples of cells expressing
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Figure 5 Beclin 1 is polyubiquitinated with Lys11- and Lys63-linked chains,
and the former mediates its degradation
(A) Myc–Beclin 1 was immunoprecipitated from cells expressing Nedd4, HA–Ub or single
lysine-onlymutantsofUb.Sampleswereanalysedafterimmunoblottingwithanti-HAand-Myc
antibodies. Only Ub-Lys11 and Ub-Lys63 allowed modiﬁcation signals similar to the wild-type
Ub. (B) HeLa cells were transfected with siRNA against VPS34 in order to deplete VPS34
and destabilize Beclin 1. Myc–Beclin 1 was immunoprecipitated from cells expressing Nedd4,
HA–Ub, Lys63 only or Lys11 only versions after MG132-treatment. Samples were analysed with
anti-HA and anti-Myc antibodies. Only Ub-Lys11 allowed modiﬁcations with similar intensity to
the wild-type Ub. IB, immunoblot; IP, immunoprecipitation; TCL, total cell lysate.
Ub-Lys
11 showed a ubiquitination pattern comparable with the
wild-type Ub, the Lys
11-linked polyubiquitin chains mediated
the enhanced ubiquitination of Beclin 1 induced by the depletion
of VPS34. These results suggest that Nedd4 catalyses the Lys
11-
linked polyubiquitination of Beclin 1 in order to regulate its
turnover. This Lys
11-linked poyubiquitination and degradation
are enhanced when the stabilizing interaction partner VPS34 is
depleted.
DISCUSSION
Owing to the important functional role of Beclin 1 in the context
of PI3K-III mediated signalling, the availability of active Beclin
1 is governed by several layers of regulation [5,6]. In the present
study we present evidence suggesting a novel mode of regulation
of Beclin 1, namely via Nedd4-catalysed polyubiquitination and
subsequent proteasomal degradation.
We have established that Beclin 1 is a ligand for WW domains,
as it contains an evolutionarily conserved PY motif and interacts
in yeast two-hybrid assays with the WW domain of Nedd4, and
to a lower extent with the WW motifs of Nedd4-2 and AIP4.
The interaction between PY and WW domains is believed to
be very speciﬁc, and the fact that Beclin 1 interacts with all three
testedWWdomainshintsatatopicwhichisintensivelydiscussed
for other targets of Nedd4-like ligases as well, namely the
question of substrate speciﬁcity and redundancy of ligases [30].
There are examples of proteins that bind to evolutionarily distant
Nedd4 family members, such as N4WBP5, which associates
with the WW domains of six different Nedd4-like proteins [31].
Additionally, it also has to be taken into account that sequences
outside of the WW domain may contribute to substrate speciﬁcity
[32] as well as the quality of the binding. This is indicated by
the observation that the Y352A mutation of Beclin 1 does not
completely abolish the interaction with Nedd4.
In summary, the data from our in vivo ubiquitination and
stability experiments suggest that Nedd4 can be regarded as the
main HECT ligase implicated in Beclin 1 ubiquitination. The
reciprocity with which Nedd4 and VPS34 inﬂuence the stability
of Beclin 1 is of interest. A possible molecular explanation
could be derived from the situation where the ECD and the
PY motif are in close proximity. This could hypothetically
hint at a sterical competition of VPS34 and Nedd4 for this
region of Beclin 1, suggesting that VPS34 might dynamically
reduce the accessibility of the PY motif to a certain extent.
Similarmodesofregulationhavebeenobservedforotherproteins.
For instance, the PY motifs of ENaC (epithelial Na
+ channel)
and ACK1 (activated Cdc42-associated tyrosine kinase 1) are
recognized by N4WBP5A or WWox respectively, which in turn
stabilize their interaction partner by reducing the probability of
an interaction to Nedd4-like ligases [33,34].
Cross-linking studies have suggested that only 50% of
mammalian VPS34 is bound to Beclin 1, whereas the entire
pool of Beclin 1 may be associated with the kinase [35]. It is
conceivable that the regulation of VPS34 stability is independent
of Beclin 1, whereas the stability of Beclin 1 itself depends on its
major interaction partner VPS34. Thus VPS34 functions either
indirectly as an assembly factor or directly as a constant binding
partner in order to stabilize Beclin 1.
siRNA-mediated depletion of VPS34 results in a reduced level
ofBeclin1[19].OurﬁndingthatNedd4mediatesthisdegradation
via Lys
11-linked polyubiquitin chains adds to the recent and
relatively short literature on this type of post-translational
modiﬁcation. In general, Lys
11-linked chains are reported to
function as targeting factors for proteasomal degradation [36].
The known examples are connected to cell cycle control as well
as some parts of the ERAD (endoplasmic-reticulum-associated
degradation) pathway [36,37]. Beclin 1 is the ﬁrst known tumour
suppressor shown to be targeted by this pathway, which raises the
theoreticalpossibilityoftargetingLys
11-linkedpolyubiquitination
in order to maintain tumour suppressor functions.
Although we could deﬁne a functional link between Nedd4 and
the Lys
11-linked ubiquitination of Beclin 1, which is especially
evident under conditions when VPS34 is depleted and Beclin
1 is destabilized, we found that the Lys
63-linked chains are not
required under these conditions. However, similar to the Lys
11-
linked chains, the Lys
63-linked chains could be attached to Beclin
1 to participate in the regulation of the steady-state concentration
of Beclin 1 when VPS34 is not destabilized. Furthermore,
Lys
63-linked chains catalysed by Rsp5 on different substrates
can serve as targeting signal for proteasomal degradation [29].
However, most of the literature on the Lys
63-linked chains
focuses on non-proteasomal functions such as targeting to the
lysosome [38]. A recent study described ubiquitination of Beclin
1 with a Lys
63-linked chain by the RING-type ligase TRAF6
[18]. The chain is attached to the BH3 domain of Beclin 1
in response to pro-inﬂammatory stimuli. This non-degradative
mechanism was proposed to function as a pro-autophagic signal,
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as it reduced the interaction with the autophagy inhibitor Bcl-
2. Thus, although TRAF6-catalysed ubiquitination of Beclin 1
supports its function non-proteolytically, at least the Lys
11-linked
ubiquitination catalysed by Nedd4 results in its degradation.
This functional distribution is reminiscent of another target of
TRAF6 and Nedd4-like ligases, the nerve growth factor receptor
TrkA.AlthoughbothTRAF6andNedd4-2supportinternalization
and signalling of TrkA, TRAF6-dependent ubiquitination is
supposed to function non-proteolytically, whereas Nedd4-2-
mediated ubiquitination results in the degradation of this plasma
membrane receptor [39,40].
TheresultsshowingNedd4-mediateddegradationofBeclin1in
the present study point to a proteolysis-based regulation of Beclin
1. As the entire pool of Beclin 1 is not turned over rapidly, the
degradation is likely to be context-dependent. For instance, this
processcouldwellrepresentaqualitycontrolmechanismwhichis
signiﬁcantly enhanced when the main interaction partner VPS34
is depleted. Further work will have to be performed to address
the question of how the Nedd4-catalysed Ub chains are linked
to the context-dependent physiological function of Beclin 1 and
the PI3K-III complex during autophagy, endocytic trafﬁcking,
signalling, cytokinesis and, as a possible consequence thereof,
the potential concentration-dependent positive or negative effects
of Beclin 1 on tumorigenesis.
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